- Home
- PRFX vs ATCH Comparison
PRFX vs ATCH Comparison
Compare PRFX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- ATCH
- Stock Information
- Founded
- PRFX 2007
- ATCH 2022
- Country
- PRFX Israel
- ATCH United States
- Employees
- PRFX 6
- ATCH N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- PRFX Health Care
- ATCH
- Exchange
- PRFX Nasdaq
- ATCH Nasdaq
- Market Cap
- PRFX 3.3M
- ATCH 2.5M
- IPO Year
- PRFX 2020
- ATCH N/A
- Fundamental
- Price
- PRFX $1.69
- ATCH $0.19
- Analyst Decision
- PRFX Hold
- ATCH
- Analyst Count
- PRFX 1
- ATCH 0
- Target Price
- PRFX N/A
- ATCH N/A
- AVG Volume (30 Days)
- PRFX 8.5M
- ATCH 33.6M
- Earning Date
- PRFX 08-29-2025
- ATCH 09-02-2025
- Dividend Yield
- PRFX N/A
- ATCH N/A
- EPS Growth
- PRFX N/A
- ATCH N/A
- EPS
- PRFX N/A
- ATCH N/A
- Revenue
- PRFX N/A
- ATCH $14,825,966.00
- Revenue This Year
- PRFX N/A
- ATCH N/A
- Revenue Next Year
- PRFX N/A
- ATCH N/A
- P/E Ratio
- PRFX N/A
- ATCH N/A
- Revenue Growth
- PRFX N/A
- ATCH 1066.77
- 52 Week Low
- PRFX $1.25
- ATCH $0.14
- 52 Week High
- PRFX $16.63
- ATCH $26.94
- Technical
- Relative Strength Index (RSI)
- PRFX 54.34
- ATCH 49.97
- Support Level
- PRFX $1.57
- ATCH $0.17
- Resistance Level
- PRFX $3.59
- ATCH $0.25
- Average True Range (ATR)
- PRFX 0.22
- ATCH 0.03
- MACD
- PRFX 0.05
- ATCH 0.00
- Stochastic Oscillator
- PRFX 18.80
- ATCH 39.28
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.